Thomas Muster

7.5k total citations · 3 hit papers
51 papers, 6.1k citations indexed

About

Thomas Muster is a scholar working on Epidemiology, Immunology and Molecular Biology. According to data from OpenAlex, Thomas Muster has authored 51 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Epidemiology, 28 papers in Immunology and 16 papers in Molecular Biology. Recurrent topics in Thomas Muster's work include Influenza Virus Research Studies (33 papers), Respiratory viral infections research (15 papers) and Immune Response and Inflammation (13 papers). Thomas Muster is often cited by papers focused on Influenza Virus Research Studies (33 papers), Respiratory viral infections research (15 papers) and Immune Response and Inflammation (13 papers). Thomas Muster collaborates with scholars based in Austria, United States and Russia. Thomas Muster's co-authors include Peter Palese, Adolfo Garcı́a-Sastre, Alexandra Trkola, Martin Purtscher, H. Katinger, A. Klima, Andrej Egorov, Franz Steindl, Sabine Brandt and Hongyong Zheng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cancer Research.

In The Last Decade

Thomas Muster

50 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

1996 925 citations Alexandra Trkola, Martin Purtscher et al. Journal of Virology profile →
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1

1993 850 citations Thomas Muster, Martin Purtscher et al. Journal of Virology profile →
Influenza A Virus Lacking the NS1 Gene Replicates in Interferon-Deficient Systems

1998 825 citations Adolfo Garcı́a-Sastre, Andrej Egorov et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Muster Austria	30	3.2k	2.8k	2.0k	1.7k	1.6k	51	6.1k
Hana Golding United States	49	4.3k 1.3×	3.5k 1.2×	2.7k 1.3×	2.0k 1.2×	1.8k 1.1×	184	8.2k
Zhi-Yong Yang United States	39	2.4k 0.7×	2.1k 0.7×	2.2k 1.1×	3.1k 1.9×	2.1k 1.2×	54	7.0k
Shan Lu United States	40	2.4k 0.8×	1.6k 0.6×	1.9k 1.0×	1.7k 1.0×	1.6k 1.0×	168	5.3k
Wing-Pui Kong United States	32	1.9k 0.6×	2.4k 0.9×	928 0.5×	2.4k 1.5×	1.4k 0.8×	40	5.4k
Alicia Buckler‐White United States	44	3.0k 0.9×	2.3k 0.8×	5.0k 2.5×	2.9k 1.8×	1.7k 1.0×	107	7.4k
Jody Manischewitz United States	36	2.1k 0.7×	3.1k 1.1×	1.6k 0.8×	1.1k 0.6×	916 0.6×	77	5.0k
Patricia L. Earl United States	54	3.5k 1.1×	3.6k 1.3×	7.0k 3.5×	2.4k 1.4×	3.0k 1.8×	131	9.4k
Gregory R. Reyes United States	39	1.5k 0.5×	2.1k 0.8×	2.3k 1.1×	4.3k 2.6×	1.0k 0.6×	76	8.1k
A J Langlois United States	39	2.8k 0.9×	1.6k 0.6×	5.4k 2.7×	2.5k 1.5×	2.0k 1.2×	83	7.0k
Robin A. Weiss United Kingdom	20	2.5k 0.8×	920 0.3×	3.0k 1.5×	1.5k 0.9×	969 0.6×	40	5.0k

Countries citing papers authored by Thomas Muster

Since Specialization

Citations

This map shows the geographic impact of Thomas Muster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Muster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Muster more than expected).

Fields of papers citing papers by Thomas Muster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Muster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Muster. The network helps show where Thomas Muster may publish in the future.

Co-authorship network of co-authors of Thomas Muster

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Muster. A scholar is included among the top collaborators of Thomas Muster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Muster. Thomas Muster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rathnasinghe, Raveen, Lauren A. Chang, Rebecca L. Pearl, et al.. (2024). Sequential immunization with chimeric hemagglutinin ΔNS1 attenuated influenza vaccines induces broad humoral and cellular immunity. npj Vaccines. 9(1). 169–169. 4 indexed citations

Rathnasinghe, Raveen, Mirella Salvatore, Hongyong Zheng, et al.. (2021). Interferon mediated prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine lacking non-structural protein 1. Scientific Reports. 11(1). 22164–22164. 10 indexed citations

Jindra, Christoph, et al.. (2021). Influenza virus vector iNS1 expressing bovine papillomavirus 1 (BPV1) antigens efficiently induces tumour regression in equine sarcoid patients. PLoS ONE. 16(11). e0260155–e0260155. 7 indexed citations

Muster, Thomas, et al.. (2014). Intranasal vaccination with a replication-deficient influenza virus induces heterosubtypic neutralising mucosal IgA antibodies in humans. Vaccine. 32(17). 1897–1900. 26 indexed citations

Nakowitsch, Sabine, Nina Wressnigg, Emanuele Montomoli, et al.. (2013). Egg‐ or cell culture‐derived hemagglutinin mutations impair virus stability and antigen content of inactivated influenza vaccines. Biotechnology Journal. 9(3). 405–414. 19 indexed citations

Wolzt, Michael, et al.. (2013). Phase I/II trial of a replication-deficient trivalent influenza virus vaccine lacking NS1. Vaccine. 31(52). 6194–6200. 44 indexed citations

Rikxoort, Marijke van, Martin Michaelis, Markus Wolschek, et al.. (2012). Oncolytic Effects of a Novel Influenza A Virus Expressing Interleukin-15 from the NS Reading Frame. PLoS ONE. 7(5). e36506–e36506. 38 indexed citations

Krenn, Brigitte M., Julia Romanova, Sabine Nakowitsch, et al.. (2011). Antimycotic-Antibiotic Amphotericin B Promotes Influenza Virus Replication in Cell Culture. Journal of Virology. 85(21). 11139–11145. 16 indexed citations

Ogbomo, Henry, Martin Michaelis, Janina Geiler, et al.. (2009). Tumor cells infected with oncolytic influenza A virus prime natural killer cells for lysis of resistant tumor cells. Medical Microbiology and Immunology. 199(2). 93–101. 23 indexed citations

10.

Wressnigg, Nina, Daniel Voß, Thorsten Wolff, et al.. (2009). Development of a live-attenuated influenza B ΔNS1 intranasal vaccine candidate. Vaccine. 27(21). 2851–2857. 29 indexed citations

11.

Wressnigg, Nina, Anna-Polina Shurygina, Thorsten Wolff, et al.. (2009). Influenza B mutant viruses with truncated NS1 proteins grow efficiently in Vero cells and are immunogenic in mice. Journal of General Virology. 90(2). 366–374. 20 indexed citations

12.

Ferko, Boris, et al.. (2008). Azidothymidine inhibits melanoma cell growth in vitro and in vivo. Melanoma Research. 18(5). 314–321. 27 indexed citations

13.

Wolff, Klaus, et al.. (2006). Sequence variability of retroviral particles derived from human melanoma cells. Virus Research. 123(2). 211–215. 12 indexed citations

14.

Salvatore, Mirella, Christopher F. Basler, Jean-Patrick Parisien, et al.. (2002). Effects of Influenza A Virus NS1 Protein on Protein Expression: the NS1 Protein Enhances Translation and Is Not Required for Shutoff of Host Protein Synthesis. Journal of Virology. 76(3). 1206–1212. 102 indexed citations

15.

Salvatore, Mirella, Robert E. O’Neill, Hongyong Zheng, et al.. (2000). Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach. Proceedings of the National Academy of Sciences. 97(8). 4309–4314. 260 indexed citations

16.

Palese, Peter, et al.. (1999). Learning from our foes: a novel vaccine concept for influenza virus. PubMed. 15. 131–138. 13 indexed citations

17.

Ferko, Boris, Dietmar Katinger, Andreas Grassauer, et al.. (1998). Chimeric Influenza Virus Replicating Predominantly in the Murine Upper Respiratory Tract Induces Local Immune Responses against Human Immunodeficiency Virus Type 1 in the Genital Tract. The Journal of Infectious Diseases. 178(5). 1359–1368. 42 indexed citations

18.

Egorov, Andrej, Sabine Brandt, Sabine Sereinig, et al.. (1998). Transfectant Influenza A Viruses with Long Deletions in the NS1 Protein Grow Efficiently in Vero Cells. Journal of Virology. 72(8). 6437–6441. 186 indexed citations

19.

Purtscher, Martin, Alexandra Trkola, Andreas Grassauer, et al.. (1996). Restricted antigenic variability of the epitope recognized by the neutralizing gp41 antibody 2F5. AIDS. 10(6). 587–594. 142 indexed citations

20.

Bergmann, Michael & Thomas Muster. (1995). The relative amount of an influenza A virus segment present in the viral particle is not affected by a reduction in replication of that segment. Journal of General Virology. 76(12). 3211–3215. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact